0000000000124117

AUTHOR

Françoise Goirand

showing 14 related works from this author

Pharmacokinetic evaluation of esomeprazole for the treatment of gastroesophageal reflux disease

2014

Proton pump inhibitors (PPIs) are widely used for the treatment of acid-related diseases such as gastroesophageal reflux disease (GERD). They are recommended by the American College of Gastroenterology for healing erosive esophagitis (EO) and as long-term treatment in patients with healed EO. The available PPIs differ somewhat in their pharmacokinetics and clinical properties, but whether these differences are of clinical relevance is a matter of debate. Some safety concerns have been raised with the use of PPIs, mostly an increased incidence of infectious diseases such as community-acquired pneumonia or Clostridium difficile diarrhea.This article explores the results of clinical studies on…

medicine.medical_specialtyDiseaseToxicologyGastroenterologyEsomeprazolePharmacokineticsInternal medicinemedicineEsophagitisHumansClinical significanceIntensive care medicinePharmacologybusiness.industryIncidenceIncidence (epidemiology)Public healthEsomeprazoleProton Pump InhibitorsStereoisomerismGeneral Medicinemedicine.diseasePneumoniaGastroesophageal RefluxGERDbusinessmedicine.drugExpert Opinion on Drug Metabolism & Toxicology
researchProduct

Stimulation of the ADRB3 Adrenergic Receptor Induces Relaxation of Human Placental Arteries: Influence of Preeclampsia1

2006

Preeclampsia, which complicates 3-8% of pregnancies, is one of the leading causes of neonatal morbidity and mortality. Its pathophysiology remains unclear. The aim of the present study was to investigate the presence and the role of beta2- and beta2-adrenergic receptors (ADRB2 and ADRB3, respectively) in human placental arteries and to assess the influence of preeclampsia on ADRB responsiveness. SR 59119A, salbutamol, and isoproterenol (ADRB3, ADRB2, and nonselective ADRB agonists, respectively) induced a concentration-dependent relaxation of placental artery rings obtained from women with uncomplicated or preeclamptic pregnancies. SR 59119A-induced relaxation was unaffected by the blockade…

0303 health sciencesmedicine.medical_specialtyAdrenergic receptorAdrenergicCell BiologyGeneral MedicinePropranolol030204 cardiovascular system & hematologyBiologymedicine.disease3. Good healthPreeclampsia03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureEndocrinologyReproductive MedicineInternal medicinePlacentamedicineSalbutamolReceptor030304 developmental biologyArterymedicine.drugBiology of Reproduction
researchProduct

Effects of Leptin on Lipopolysaccharide-Induced Remodeling in an In Vitro Model of Human Myometrial Inflammation1

2013

Reorganization of myometrial extracellular matrix (ECM) is essential for the uterus to achieve powerful synchronous contractions during labor. Remodeling of the ECM has been implicated in membrane rupture and cervical ripening. Because maternal obesity is associated with both delivery disorders and elevated circulating leptin levels, this study aimed to assess the ability of leptin to interfere with lipopolysaccharide (LPS)-induced myometrial ECM remodeling. Myometrial biopsy samples were obtained from women undergoing cesarean delivery before labor onset. Myometrial explants were incubated for 48 h with LPS and leptin. LPS challenge was associated with a marked decrease in collagen content…

medicine.medical_specialtyMMP2LeptinMyometriumInflammationCell BiologyGeneral MedicineBiologyMatrix metalloproteinaseMMP9Extracellular matrixEndocrinologyReproductive MedicineInternal medicineHeat shock proteinmedicinemedicine.symptomBiology of Reproduction
researchProduct

SAR150640, a selective β3-adrenoceptor agonist, prevents human myometrial remodelling and activation of matrix metalloproteinase in an in vitro model…

2010

Background and purpose:  The uterine pathophysiology underlying inflammatory conditions such as chorioamnionitis remains largely unclear. As we have shown that β3-adrenoceptors act as regulators of myometrial inflammation, we wanted to investigate the potential role of β3-adrenoceptors in preventing uterine remodelling induced by inflammation. Experimental approach:  The consequences of human chorioamnionitis on myometrial remodelling were characterized by Sirius Red staining and metalloproteinase (MMP) expression, and compared with the effects of incubating human myometrial samples with Escherichia coli lipopolysaccharide (LPS) in vitro. We also assessed the effect of SAR150640, a selectiv…

PharmacologyAgonistmedicine.medical_specialtyMetalloproteinasemedicine.drug_classMyometriumInflammationMatrix metalloproteinaseMMP9BiologyChorioamnionitismedicine.diseasechemistry.chemical_compoundEndocrinologychemistryInternal medicinemedicinemedicine.symptomSirius RedBritish Journal of Pharmacology
researchProduct

Changes in Maternal Blood Inflammatory Markers As a Predictor Of Chorioamnionitis: A Prospective Multicenter Study

2014

Problem To evaluate the inflammatory pattern in maternal circulation from women with preterm premature rupture of membranes (PPROM) considering the occurrence of histologically confirmed chorioamnionitis (HCA). Method of study A prospective study was conducted in 121 women with PPROM between 24 and 34 + 0 weeks of gestation. Association between white blood cells (WBC) count, plasma CRP, IL-6, MCP-1 and IP-10 levels, and HCA was assessed. Results The rate of HCA was 44.7% (54/121). During the 5 days preceding delivery, median CRP, WBC, and IL-6 levels were significantly higher in the HCA than in no-HCA group (P < 0.001). Variations in IL-6, IP-10 levels, during the 24–72 hr before delivery, …

Adultmedicine.medical_specialtyPathologyImmunologyChorioamnionitisGastroenterologyLeukocyte CountObstetric Labor PrematurePredictive Value of TestsPregnancyInternal medicinemedicineHumansImmunology and AllergyPlacental CirculationAmnionProspective StudiesProspective cohort studyRupturePregnancybiologybusiness.industryC-reactive proteinArea under the curveObstetrics and GynecologyPrognosismedicine.diseaseC-Reactive ProteinChorioamnionitisReproductive MedicinePredictive value of testsbiology.proteinCytokinesGestationFemaleInflammation MediatorsbusinessPremature rupture of membranesBiomarkersFollow-Up StudiesAmerican Journal of Reproductive Immunology
researchProduct

Postnatal overfeeding in rats leads to moderate overweight and to cardiometabolic and oxidative alterations in adulthood.

2011

In contrast to the masses of data on obesity, few data are available concerning the cardiometabolic and oxidative consequences of moderate overweight. The model of postnatal overfeeding (OF) induces an increase in body weight at weaning that remains during adult life. Litters of Wistar rats were either maintained at 12 pups (normal-fed group, NF), or reduced to 3 pups at birth in order to induce OF. At 6 months of age, metabolic parameters, circulating oxidative stress and aortic and coronary vasoreactivity were assessed. Cardiac susceptibility to ischemia-reperfusion injury was also evaluated ex vivo as were markers of cardiac remodeling. OF led to an increase in body weight at weaning (+5…

Blood GlucoseLeptinleft ventricular end-systolic pressuremedicine.medical_treatment030204 cardiovascular system & hematologyOverweight+dP/dtmedicine.disease_causeBiochemistryCardiovascular System0302 clinical medicineOvernutritionHRleft ventricular developed pressureheart rateInsulinhydroperoxidesworking modeComputingMilieux_MISCELLANEOUSmatrix metallo-proteinase-2W0303 health sciencesANOVAMMP-2OFLeptinROOHinternational unitsGeneral MedicineLsuperoxide dismutase[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemleft ventricular maximal pressure developmentFemalemedicine.symptomleft ventricular end-diastolic pressureanalysis of variancemedicine.medical_specialtyLDHNFleft ventricular minimal pressure developmentIschemiaSNPbody mass indexheartReal-Time Polymerase Chain Reactionoxidative stress AchBMI03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemLangendorff modeoverfeedingInternal medicineRLUBKmedicineWeaningAnimalsLVEDPSODRats WistarVentricular remodeling030304 developmental biologyDNA PrimersPostnatal overfeedingBase Sequencebusiness.industryInsulinsodium nitroprussiatelactate dehydrogenaseLVDPLVESPOverweightrelative light unitsmedicine.diseaseacetylcholinearbitrary unitsRatsIUOxidative StressEndocrinology−dP/dtAUnormal-fedbradykininbusinessEx vivoOxidative stressBiochimie
researchProduct

Dexlansoprazole Delayed Release: Pharmacotherapy of Erosive Esophagitis and GERD

2011

Dexlansoprazole MR is a modified release formulation of the R-enantiomer of lansoprazole, which employs a novel Dual Delayed Release (DDR) technology. Pharmacokinetic studies have shown that the DDR technology provides a two peaks drug release, accuring 1–2 hours and 4–5 hours after dosing, leading to an extended duration of therapeutic plasma drug concentrations compared with conventional delayed release lansoprazole. Dexlansoprazole MR 30 and 60 mg provided superior intragastric pH control compared to that obtained with lansoprazole 15 mg and 30 mg once daily dosing. Dexlansoprazole can be taken without regard to food. The drug has been shown to be as efficacious as lansoprazole in heali…

PharmacologyDrugmedicine.medical_specialtybusiness.industrymedia_common.quotation_subjectlcsh:RM1-950LansoprazolePharmaceutical ScienceGeneral Medicinemedicine.diseasePlaceboGastroenterologylcsh:Therapeutics. PharmacologyPharmacotherapyPharmacokineticsInternal medicineGERDmedicineDexlansoprazoleDosingbusinessmedia_commonmedicine.drugBiomedical engineeringClinical Medicine Insights: Therapeutics
researchProduct

Pharmacokinetic and clinical evaluation of esomeprazole and ASA for the prevention of gastroduodenal ulcers in cardiovascular patients.

2012

Low-dose aspirin (ASA, 75 - 325 mg/day) is widely used for the primary and secondary prevention of cardiovascular (CV) diseases. However, the value of primary prevention ASA is uncertain as the reduction in occlusive events needs to be weighed against the significant increase in major bleedings. Prevention with antisecretory drugs has been proposed to reduce the incidence of ASA-induced gastrointestinal (GI) bleedings, but non-adherence to gastro-protection is of concern, as it significantly increases the risk of upper GI adverse events. Beside patients and physicians education, one approach to overcome non-adherence is the development of fixed-dose combination.This review explores the resu…

medicine.medical_specialtyPeptic UlcerToxicologyGastroenterologyEsomeprazolePharmacokineticsInternal medicinemedicineHumansIn patientDrug InteractionsAdverse effectRandomized Controlled Trials as TopicPharmacologyAspirinAspirinbusiness.industryIncidence (epidemiology)EsomeprazoleGeneral MedicineAnti-Ulcer Agentsdigestive system diseasesGastroduodenal ulcerCardiovascular DiseasesbusinessClinical evaluationPlatelet Aggregation Inhibitorsmedicine.drugExpert opinion on drug metabolismtoxicology
researchProduct

Arachidonic acid relaxes human pulmonary arteries through K+ channels and nitric oxide pathways.

2004

We aimed to investigate the role of K(+) channels and nitric oxide (NO) on the relaxant effects of arachidonic acid in the human intralobar pulmonary arteries. Arachidonic acid produced a concentration-dependent relaxation (E(max)=93+/-3% of maximal relaxation induced by papaverine 0.1 mM;-log EC(30)=7.03+/-0.09) that was antagonized by the cyclooxygenase inhibitor indomethacin (1 microM), by the combination of cyclooxygenase blockade and cytochrome P450 (CYP) blockade with 17-octadecynoic acid (17-ODYA, 10 microM), by the combination of cyclooxygenase inhibition and NO synthase (NOS) inhibition with N(omega)-nitro-l-arginine (l-NOARG, 100 microM), by the simultaneous inhibition of CYP and …

PharmacologyArachidonic AcidPotassium ChannelsCharybdotoxinDose-Response Relationship DrugStereochemistryPharmacologyIn Vitro TechniquesPulmonary ArteryApaminNitric OxidePotassium channelNitric oxideGlibenclamideVasodilationchemistry.chemical_compoundchemistrymedicineHumansArachidonic acidChannel blockerUnsaturated fatty acidmedicine.drugSignal TransductionEuropean journal of pharmacology
researchProduct

Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure

2020

In order to limit 5-fluorouracil (5-FU) toxicity, some health agencies recommend evaluating dihydropyrimidine dehydrogenase (DPD) deficiency before any 5-FU treatment introduction. In our study, we investigated relationships between 5-FU clearance and markers of DPD activity such as uracilemia (U), dihydrouracilemia (UH2)/U ratio, or genotype of the gene encoding DPD (DPYD). All patients with gastrointestinal cancers who received 5-FU-based regimens form March 2018 to June 2020 were included in our study. They routinely benefited of a pre-therapeutic DPYD genotyping and phenotyping. During 5-FU infusion, blood samples were collected to measure 5-FU steady-state concentration in order to ada…

0301 basic medicinemedicine.medical_specialtyUH2/U ratioFOLFIRINOXtherapeutic drug monitoringuracilemiaPharmaceutical Sciencelcsh:Medicinelcsh:RS1-441GastroenterologyArticlelcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicinePharmacokineticsInternal medicineDrug DiscoveryDihydropyrimidine dehydrogenaseMedicine5-FUmedicine.diagnostic_testbusiness.industrylcsh:RDPDmedicine.diseasePrimary tumorGI cancer030104 developmental biologyDocetaxelTherapeutic drug monitoring030220 oncology & carcinogenesisToxicityUH<sub>2</sub>/U ratioMolecular MedicineDPYDbusinesspharmacokineticsmedicine.drugPharmaceuticals
researchProduct

Lack of everolimus diffusion in pleural fluid during pleural progression of breast cancer: A case report

2020

Background We report here a case where no everolimus pleural diffusion was evidenced at the same time of pleural progression of a metastatic breast cancer treated with everolimus and exemestane. Case description A 69-year-old woman was diagnosed in October 2006 with stage III invasive ductal breast adenocarcinoma. After nine months of everolimus and exemestane treatment, she presented with a pleural progression. Everolimus concentration was measured in blood and in pleural fluid. Residual blood concentration was at 9.1 ng/mL, while no everolimus was observed in the pleural fluid. Management and outcome Due to inefficacy of everolimus in this patient, she was switched to palbociclib and fulv…

Oncologymedicine.medical_specialtyPyridinesBreast NeoplasmsPiperazines03 medical and health sciences0302 clinical medicineBreast cancerInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansPharmacology (medical)EverolimusAgedEverolimusbusiness.industrymedicine.diseaseMetastatic breast cancerAndrostadienesOncology030220 oncology & carcinogenesisDisease ProgressionPleural fluidFemalebusiness030215 immunologymedicine.drugJournal of Oncology Pharmacy Practice
researchProduct

Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases.

2021

Interstitial lung diseases (ILDs) include a large number of diseases and causes with variable outcomes often associated with progressive fibrosis. Although each of the individual fibrosing ILDs are rare, collectively, they affect a considerable number of patients, representing a significant burden of disease. Idiopathic pulmonary fibrosis (IPF) is the typical chronic fibrosing ILD associated with progressive decline in lung. Other fibrosing ILDs are often associated with connective tissues diseases, including rheumatoid arthritis-ILD (RA-ILD) and systemic sclerosis-associated ILD (SSc-ILD), or environmental/drug exposure. Given the vast number of progressive fibrosing ILDs and the dispariti…

QH301-705.5DiseaseReviewbehavioral disciplines and activitiesCatalysisextracellular HSPInorganic ChemistryIdiopathic pulmonary fibrosisFibrosisHeat shock proteinmedicineExtracellularAnimalsHumansinterstitial lung diseasesMolecular Targeted TherapyPhysical and Theoretical ChemistryBiology (General)Molecular BiologyQD1-999SpectroscopyHeat-Shock ProteinsLungbusiness.industryOrganic Chemistrylung fibrosisCancerGeneral Medicinerespiratory systemmedicine.diseaseIdiopathic Pulmonary FibrosisComputer Science Applicationsrespiratory tract diseasesbody regionsChemistrymedicine.anatomical_structureIPFImmunologyheat shock proteinsDisease ProgressionBiomarker (medicine)biomarkerbusinessLung Diseases InterstitialBiomarkersInternational journal of molecular sciences
researchProduct

Adrb3 adrenergic receptor is a key regulator of human myometrial apoptosis and inflammation during chorioamnionitis1

2008

The pathophysiology underlying preterm labor triggered by inflammatory conditions such as chorioamnionitis remains largely unclear. It has already been suggested that beta-3 adrenergic (ADRB3) agonists might be of interest in the pharmacological management of preterm labor. Although there is evidence implicating ADRB receptors in the control of inflammation, there are minimal data relating specifically to ADRB3. To explore the cellular consequences of chorioamnionitis and detect apoptosis, we first performed immunostaining and Western blot experiments on human myometrial samples obtained from women with confirmed chorioamnionitis. We then developed an in vitro model of chorioamnionitis by i…

preterm labormedicine.medical_specialtymedicine.medical_treatmentunited-statesbeta-adrenoceptorsStimulationInflammationin-vitroChorioamnionitisProinflammatory cytokineimmunology03 medical and health sciences0302 clinical medicineInternal medicinemedicineInterleukin 8Interleukin 6030304 developmental biology0303 health sciencesbiologycell apoptosislipopolysaccharideapoptosisbacterial infectionCell BiologyGeneral Medicinemedicine.diseasegene-expressioncytokines3. Good healthEndocrinologyCytokineReproductive Medicineinflammation030220 oncology & carcinogenesisbiology.proteincytokine productionbeta(3)-adrenoceptorTumor necrosis factor alphapregnancymedicine.symptomdeliverytumor-necrosis-factorterm
researchProduct

Time course of asymmetric dimethylarginine (ADMA) and oxidative stress in fructose-hypertensive rats: A model related to metabolic syndrome

2011

Asymmetric dimethylarginine (ADMA) is an endogenous modulator of endothelial function and oxidative stress, and increased levels of this molecule have been reported in some metabolic disorders and cardiovascular diseases. The aim of this work was to analyze the time course of dimethylarginine compounds and oxidative stress levels and the relationship between these and cardiovascular function in fructose-hypertensive rats.90 male Sprague-Dawley rats were randomized into 2 groups, fed for 3 months with standard (C) chow supplemented or not with fructose (F, 60%). After sacrifice at different weeks (W), the aorta and plasma were harvested to assess the vascular and biochemical parameters. Our …

Blood GlucoseMaleTime FactorsVasodilator AgentsNitric Oxide Synthase Type IIBlood Pressure030204 cardiovascular system & hematologymedicine.disease_causeRats Sprague-Dawleychemistry.chemical_compound0302 clinical medicineHeart RateEnzyme InhibitorsAortaComputingMilieux_MISCELLANEOUSMetabolic Syndrome0303 health sciencesOxidase testVasodilationNAD(P)H oxidaseHypertensionCardiology and Cardiovascular Medicinemedicine.medical_specialtyFructoseArginine03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInternal medicinemedicine.arterymedicineAnimals030304 developmental biologyAortaDose-Response Relationship Drugbusiness.industryVascular diseaseBody WeightNADPH OxidasesFructosemedicine.diseaseRatsDisease Models AnimalOxidative StressEndocrinologychemistryTyrosineMetabolic syndromebusinessAsymmetric dimethylarginineOxidative stressAtherosclerosis
researchProduct